Literature DB >> 32740875

Face masks in radiation oncology clinics: based on evidence or source of mistakes?

Rainer J Klement1, Reinhart A Sweeney2.   

Abstract

We here express our concern about a general decree to let patients wear face masks in radiation oncology clinics. We believe that potential risks associated with wearing masks, such as the risk of confounding patients, outweigh any benefits of such a policy for which evidence of protection from COVID-19 is generally weak. For asymptomatic patients, wearing masks in addition to hygiene standards will not provide additional protection of others and should be cautioned against.

Entities:  

Keywords:  COVID-19; Face masks; Radiation oncology; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32740875      PMCID: PMC7395576          DOI: 10.1007/s12032-020-01403-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


To the editor, With some concern, we have read recent recommendations for altering radiation treatment techniques and procedures during the coronavirus disease 2019 (COVID-19) crisis. These include “avoiding use of gated breath hold techniques which require extensive therapist’s effort” or “optimal use of faster orthogonal KV imaging in preference to daily CBCT” [1]. These measures are proposed in order to avoid treatment errors that may be caused by staff members due to a general tendency to minimize patient contact and protective clothes such as face masks, leading to fogged eyeglasses, inconvenience of wearing them, and decreased focus of attention [1]. A related problem arises from the fact that patients wearing masks are prone to being confused with another patient, increasing the potential for delivering the wrong treatment plan and causing great harm. We here question the general requirement for patients and staff having to wear masks without being symptomatic. The reason is that we could not find solid evidence for the efficacy of masks against respiratory virus infection. Meta-analyses and systematic reviews of randomized controlled trials could not establish a protective effect of medical masks or N95 respirators against influenza or other respiratory virus infections [2, 3]. While observational studies related to the 2003 SARS-CoV-1 indicated an overall protective effect of medical masks, these studies were prone to bias; furthermore, no protection against SARS-CoV-1 was found for disposable, cotton, or paper masks [3]. Leung et al. [4] recently showed that mask wearing significantly reduces the viral load of coronaviruses in aerosols (≤ 5 μm) (p = 0.02), but not respiratory droplets (> 5 μm) (p = 0.07) in infected symptomatic individuals. However, viral load measured over 30 min was generally small, and 8 of 23 (35%) individuals with coronavirus did not shed any detectable virus in respiratory material at all; the same was true for four individuals with coronavirus who did not cough during the experiment. Thus, translated to COVID-19, face masks may protect others from infection if the wearer has clear symptoms of respiratory disease, but evidence for self-protection through masks in addition to hygiene standards such as hand washing and distance keeping is absent or weak, in particular when masks do not fulfill medical standards or are used accordingly. Mechanistically, with 60–140 nm [5], the SARS-CoV-2 virus would be able to penetrate even medical masks to a significant degree [6]. We, therefore, think that the potential danger of confusing patients outweighs the putative benefits of wearing a mask for asymptomatic patients. Although there exist some forms of (semi-)automatic patient identification tools which tie treatment parameters to, for example, anatomic specifics (iris, palmar venous pattern, etc.) or some non-anatomic pattern (bar code), few departments use these routinely and even these can only be part of a complete solution. Also, face masks may cover otherwise obvious pathologic clinical symptoms such as anemia, weight loss/Cushing’s symptomatic etc. Thus, even in critical times, evidence-based medicine, radiation safety, and our quite subtle and sensitive medical awareness should not be forgotten. We strongly caution against a general decree of mask wearing in radiation oncology clinics.
  6 in total

1.  Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks?

Authors:  Anna Bałazy; Mika Toivola; Atin Adhikari; Satheesh K Sivasubramani; Tiina Reponen; Sergey A Grinshpun
Journal:  Am J Infect Control       Date:  2006-03       Impact factor: 2.918

2.  Respiratory virus shedding in exhaled breath and efficacy of face masks.

Authors:  Nancy H L Leung; Daniel K W Chu; Eunice Y C Shiu; Kwok-Hung Chan; James J McDevitt; Benien J P Hau; Hui-Ling Yen; Yuguo Li; Dennis K M Ip; J S Malik Peiris; Wing-Hong Seto; Gabriel M Leung; Donald K Milton; Benjamin J Cowling
Journal:  Nat Med       Date:  2020-04-03       Impact factor: 53.440

Review 3.  The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence.

Authors:  Faisal Bin-Reza; Vicente Lopez Chavarrias; Angus Nicoll; Mary E Chamberland
Journal:  Influenza Other Respir Viruses       Date:  2011-12-21       Impact factor: 4.380

Review 4.  Radiation therapy considerations during the COVID-19 Pandemic: Literature review and expert opinions.

Authors:  Pranshu Mohindra; Courtney R Buckey; Shifeng Chen; Terence T Sio; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2020-05-14       Impact factor: 2.102

Review 5.  Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis.

Authors:  Vittoria Offeddu; Chee Fu Yung; Mabel Sheau Fong Low; Clarence C Tam
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

6.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.